TAXIS Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:TAXIS Pharmaceuticals Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013316
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
TAXIS Pharmaceuticals Inc (TAXIS Pharma) is a healthcare products company that offers drug discovery services. The company develops and discovers pharmaceuticals targeting infectious diseases. It identifies new classes of antibiotic agents use a novel mechanism of bactericidal action different from any other antibiotic in clinical use. TAXIS Pharma offers services such as research and development, chemical synthesis and laboratory services. The company’s outsources production of bulk intermediates through the US and other international suppliers. Its XA709 is used for the treatment of methicillin-resistant Staphylococcus aureus. The company’s products are used in treatment of bacterial infections, and others. TAXIS Pharma is headquartered in Monmouth Junction, New Jersey, the US.

TAXIS Pharmaceuticals Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
TAXIS Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
TAXIS Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
TAXIS Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
TAXIS Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
TAXIS Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
TAXIS Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Taxis Pharma to Raise USD5 Million in Venture Financing 10
Taxis Pharma Raises USD1.2 Million in Venture Financing 11
Taxis Pharma Raises USD3 Million in Venture Financing 12
TAXIS Pharmaceuticals Inc – Key Competitors 13
TAXIS Pharmaceuticals Inc – Key Employees 14
TAXIS Pharmaceuticals Inc – Locations And Subsidiaries 15
Head Office 15
Recent Developments 16
Product News 16
09/07/2016: FDA Grants Special Designation to TAXIS Pharmaceuticals Experimental Antibiotic: 16
Clinical Trials 17
Jun 13, 2016: Experimental Antibiotic Treats Deadly MRSA Infection 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
TAXIS Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts 2
TAXIS Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
TAXIS Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
TAXIS Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
TAXIS Pharmaceuticals Inc, Deals By Therapy Area, 2011 to YTD 2017 8
TAXIS Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Taxis Pharma to Raise USD5 Million in Venture Financing 10
Taxis Pharma Raises USD1.2 Million in Venture Financing 11
Taxis Pharma Raises USD3 Million in Venture Financing 12
TAXIS Pharmaceuticals Inc, Key Competitors 13
TAXIS Pharmaceuticals Inc, Key Employees 14

★海外企業調査レポート[TAXIS Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • ethris GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary Ethris GmbH (Ethris) is a biotech company that develops RNA-based therapies. The company develops therapeutics based on its proprietary platform technologies. It uses technologies including magnetovax and SNIM RNA. Ethris’ magnetovax is a platform for personalized tumor vaccines localized an …
  • Ascendance Biotechnology Inc-製薬・医療分野:企業M&A・提携分析
    Summary Ascendance Biotechnology Inc (Ascendance), formerly Hepregen Corp is a healthcare products provider that offers cell based assay products. The company provides vitro micro-liver cell-based platforms for use in safety testing, and pharmaceutical, biotherapeutic and diagnostic product developm …
  • Bailian Group Co., Ltd.:企業の戦略的SWOT分析
    Bailian Group Co., Ltd. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Shopper’s Stop Ltd.:企業の戦略・SWOT・財務情報
    Shopper's Stop Ltd. - Strategy, SWOT and Corporate Finance Report Summary Shopper's Stop Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • St. George Bank:企業の戦略・SWOT・財務分析
    St. George Bank - Strategy, SWOT and Corporate Finance Report Summary St. George Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Xodus Group Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Xodus Group Ltd (Xodus) is a provider of engineering and advisory services. The company offers services such as exploration and appraisal, development, projects, asset support, decommissioning and advisory services. Its exploration services comprise regional studies, basin modelling, acreage …
  • Codexis Inc (CDXS):製薬・医療:M&Aディール及び事業提携情報
    Summary Codexis Inc (Codexis) is a protein engineering company, which develops proteins for a wide range of applications, including as biocatalysts for the commercial manufacture of pharmaceuticals, industrial enzymes and fine chemicals, and enzymes as biotherapeutics and for use in molecular diagno …
  • Teleflex Inc (TFX):企業の財務・戦略的SWOT分析
    Teleflex Inc (TFX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Laboratorios Liomont SA de CV-製薬・医療分野:企業M&A・提携分析
    Summary Laboratorios Liomont SA de CV (Liomont) is a healthcare products provider that offers research and develops medicines for medication, prescription and OTC markets. The company offers prescription medication products and over the counter products. It offers drugs in serves various therapeutic …
  • CNOOC Ltd (883)-石油・ガス分野:企業M&A・提携分析
    Summary CNOOC Limited (CNOOC) is an upstream oil and gas exploration and production company. It engages in exploration, development, production and sale of crude oil and natural gas. In offshore China, the company engages in oil and natural gas exploration, development and production in Bohai, Weste …
  • Genscript Biotech Corp (1548):製薬・医療:M&Aディール及び事業提携情報
    Summary Genscript Biotech Corp (Genscript Biotech) is a biotechnology company that provides life sciences research and application services and products. The company offers wide range of services in peptide synthesis, gene synthesis, protein expression and engineering, molecular biology, custom anti …
  • Aernnova Aerospace, S.A.:企業の戦略・SWOT・財務情報
    Aernnova Aerospace, S.A. - Strategy, SWOT and Corporate Finance Report Summary Aernnova Aerospace, S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • GH Armor Systems Inc.:企業の戦略・SWOT・財務情報
    GH Armor Systems Inc. - Strategy, SWOT and Corporate Finance Report Summary GH Armor Systems Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Emirates NBD Bank PJSC:企業の戦略・SWOT・財務情報
    Emirates NBD Bank PJSC - Strategy, SWOT and Corporate Finance Report Summary Emirates NBD Bank PJSC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Australian Postal Corporation:企業の戦略的SWOT分析
    Australian Postal Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Bankers Insurance Group:企業の戦略・SWOT・財務情報
    Bankers Insurance Group - Strategy, SWOT and Corporate Finance Report Summary Bankers Insurance Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • KDDI Corporation:戦略・SWOT・企業財務分析
    KDDI Corporation - Strategy, SWOT and Corporate Finance Report Summary KDDI Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Cerus Energy Group Ltd (CEA):石油・ガス:M&Aディール及び事業提携情報
    Summary Cerus Energy Group Ltd (Cerus Energy), formerly Petrostar Petroleum Corp is an oil and gas company that produces methanol, DME, and petroleum and natural gas. The company offers deep well disposal, storage and terminalling services, and well management services. Its well management services …
  • Protalex Inc (PRTX):製薬・医療:M&Aディール及び事業提携情報
    Summary Protalex Inc (Protalex) is a biopharmaceutical company that develops drugs for the treatment of autoimmune and inflammatory diseases. The company offers treatment for a range of autoimmune diseases such as rheumatoid arthritis and immune thrombocytopenia. Its lead product candidate includes …
  • NeoPharm Co Ltd:企業の戦略・SWOT・財務分析
    NeoPharm Co Ltd - Strategy, SWOT and Corporate Finance Report Summary NeoPharm Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆